David J Farrar
Overview
Explore the profile of David J Farrar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
3399
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Cowger J, Naka Y, Aaronson K, Horstmanshof D, Gulati S, Rinde-Hoffman D, et al.
J Heart Lung Transplant
. 2017 Nov;
37(1):15-24.
PMID: 29153637
Background: The Multicenter Study of MAGLEV Technology in Patients Undergoing Mechanical Circulatory Support Therapy with HeartMate 3 (MOMENTUM 3) clinical trial demonstrated improved 6-month event-free survival, but a detailed analysis...
12.
Thenappan T, Stulak J, Agarwal R, Maltais S, Shah P, Eckman P, et al.
J Heart Lung Transplant
. 2017 Nov;
37(1):25-32.
PMID: 29153636
Background: Hemolysis, assessed by elevated serum lactate dehydrogenase (LDH), is strongly associated with HeartMate II pump thrombosis (PT). However, it is unknown whether early intervention for elevated LDH circumvents the...
13.
Shah K, Gunda S, Emani S, Kanwar M, Uriel N, Colombo P, et al.
Circ Heart Fail
. 2017 Nov;
10(11).
PMID: 29141860
Background: Gastrointestinal (GI) bleeding is one of the most common complications after continuous-flow left ventricular assist device implantation. More than one third of patients with incident bleed go on to...
14.
Lima B, Dur O, Chuang J, Chamogeorgakis T, Farrar D, Sundareswaran K, et al.
ASAIO J
. 2017 Jul;
64(2):154-158.
PMID: 28746083
Optimal function of left ventricular assist devices (LVADs) depends on proper alignment of the inflow cannula (IC). Quantitative guidelines for IC angulation are lacking because of variation in cardiac geometry...
15.
Stehlik J, Estep J, Selzman C, Rogers J, Spertus J, Shah K, et al.
Circ Heart Fail
. 2017 Jun;
10(6).
PMID: 28611126
Background: The prospective observational ROADMAP study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management) demonstrated that ambulatory advanced heart failure patients selected for left ventricular...
16.
Lanfear D, Levy W, Stehlik J, Estep J, Rogers J, Shah K, et al.
Circ Heart Fail
. 2017 May;
10(5).
PMID: 28465311
Background: Timing of left ventricular assist device (LVAD) implantation in advanced heart failure patients not on inotropes is unclear. Relevant prediction models exist (SHFM [Seattle Heart Failure Model] and HMRS...
17.
Starling R, Estep J, Horstmanshof D, Milano C, Stehlik J, Shah K, et al.
JACC Heart Fail
. 2017 Apr;
5(7):518-527.
PMID: 28396040
Objectives: The authors sought to provide the pre-specified primary endpoint of the ROADMAP (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure...
18.
Maltais S, Kilic A, Nathan S, Keebler M, Emani S, Ransom J, et al.
J Heart Lung Transplant
. 2016 Nov;
36(1):1-12.
PMID: 27865732
Background: Recommended structured clinical practices including implant technique, anti-coagulation strategy, and pump speed management (PREVENT [PREVENtion of HeartMate II Pump Thrombosis Through Clinical Management] recommendations) were developed to address risk...
19.
Netuka I, Litzler P, Berchtold-Herz M, Flecher E, Zimpfer D, Damme L, et al.
Ann Thorac Surg
. 2016 Oct;
103(4):1262-1268.
PMID: 27743637
Background: Current recommendations of antithrombotic therapy for HeartMate II (HMII) patients include the use of both an anticoagulant and an antiplatelet agent. Because bleeding is still the most frequent adverse...
20.
Lee S, Katz J, Jorde U, Moazami N, John R, Sundareswaran K, et al.
ASAIO J
. 2016 Aug;
62(6):646-651.
PMID: 27556150
There is insufficient data on patients with small body size to determine if this should be considered a risk factor for continuous-flow left ventricular assist device (CF-LVAD) support. We sought...